Agilent Technologies (A) Issues Q2 Earnings Guidance

Agilent Technologies (NYSE:A) updated its second quarter earnings guidance on Wednesday. The company provided EPS guidance of $0.61-0.63 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.64. The company issued revenue guidance of $1.2-1.22 billion, compared to the consensus revenue estimate of $1.17 billion.Agilent Technologies also updated its FY18 guidance to $2.62-2.68 EPS.

Several brokerages have recently weighed in on A. Cowen restated a hold rating and set a $70.00 target price on shares of Agilent Technologies in a report on Wednesday, November 22nd. Evercore ISI began coverage on Agilent Technologies in a report on Wednesday, January 3rd. They set an outperform rating and a $75.00 target price on the stock. Robert W. Baird restated a buy rating and set a $72.00 target price on shares of Agilent Technologies in a report on Friday, November 24th. Zacks Investment Research upgraded Agilent Technologies from a hold rating to a buy rating and set a $76.00 target price on the stock in a report on Tuesday, October 31st. Finally, JPMorgan Chase & Co. boosted their target price on Agilent Technologies to $75.00 and gave the stock an overweight rating in a report on Tuesday, November 21st. Six investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The stock has an average rating of Buy and an average target price of $69.25.

Agilent Technologies (A) traded up $1.98 on Thursday, reaching $71.68. The company had a trading volume of 1,057,134 shares, compared to its average volume of 2,190,426. Agilent Technologies has a 12-month low of $50.56 and a 12-month high of $75.00. The firm has a market capitalization of $22,054.50, a PE ratio of 33.19, a PEG ratio of 2.06 and a beta of 1.28. The company has a quick ratio of 2.85, a current ratio of 3.30 and a debt-to-equity ratio of 0.37.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, February 14th. The medical research company reported $0.66 EPS for the quarter, beating analysts’ consensus estimates of $0.58 by $0.08. Agilent Technologies had a return on equity of 16.95% and a net margin of 15.30%. The firm had revenue of $1.21 billion for the quarter, compared to analysts’ expectations of $1.16 billion. During the same period in the prior year, the firm posted $0.53 earnings per share. equities analysts predict that Agilent Technologies will post 2.58 earnings per share for the current year.

In other Agilent Technologies news, CEO Michael R. Mcmullen sold 21,850 shares of the business’s stock in a transaction that occurred on Monday, January 29th. The stock was sold at an average price of $75.00, for a total value of $1,638,750.00. Following the sale, the chief executive officer now owns 324,687 shares of the company’s stock, valued at $24,351,525. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Mark Doak sold 4,154 shares of the business’s stock in a transaction that occurred on Tuesday, December 5th. The shares were sold at an average price of $67.00, for a total value of $278,318.00. Following the completion of the sale, the vice president now directly owns 68,270 shares in the company, valued at approximately $4,574,090. The disclosure for this sale can be found here. Insiders sold 219,991 shares of company stock worth $15,468,795 over the last quarter.

COPYRIGHT VIOLATION WARNING: “Agilent Technologies (A) Issues Q2 Earnings Guidance” was posted by Week Herald and is the sole property of of Week Herald. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of United States & international copyright laws. The original version of this piece of content can be read at

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Earnings History and Estimates for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with's FREE daily email newsletter.

Leave a Reply